Search results
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 days agoCalyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents ...
Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic...
Benzinga· 5 days agoTheriva™ Biologics TOVX is an immuno-oncology company developing oncolytic viruses, otherwise known...
This Needham biotech's stock has gone up 700% in 3 months - Boston Business Journal
The Business Journals· 1 day agoPaul Peter Tak, CEO of the immuno-oncology company, recently sat down with the Business Journal to...
Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024
Morningstar· 6 days agoAffimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced ...
Agenus (NASDAQ:AGEN) Stock Crosses Above 200-Day Moving Average of $12.95
ETF DAILY NEWS· 15 hours agoAgenus Inc. (NASDAQ:AGEN – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $12.95 and traded as high as $17.65.
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor...
Benzinga· 6 days agoWALTHAM, Mass. and DUBLIN, June 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (NASDAQ:MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks· 5 days agoFree Report) announced positive top-line results from the primary analysis of the IGNYTE study on lead pipeline candidate RP1, in combination with Bristol Myers’ (BMY Quick QuoteBMY - Free Report ...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
The Joplin Globe· 5 days agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support for Clinical Trials ...
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
Motley Fool via Yahoo Finance· 2 days agoAnd it's key because it represents a source of revenue. Meanwhile, CRISPR Therapeutics is moving...
Pyxis Oncology adds biopharma veteran to board By Investing.com
Investing.com· 24 hours agoPyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage biotechnology company developing therapies for...
